Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 11,674 | 10,781 | 11,282 | 8,781 | 0 |
| Gross Profit | 11,674 | 10,781 | 11,282 | 8,781 | N/A |
| Operating Expenses | 20,913 | 19,010 | 14,795 | 13,761 | 15,131 |
| Operating Income | -9,239 | -8,229 | -3,513 | -4,980 | -15,131 |
| Other Income | 576 | 568 | 461 | 155 | 152 |
| Pre-tax Income | -8,663 | -7,661 | -3,052 | -4,825 | -14,979 |
| Net Income Continuous | -8,663 | -7,661 | -3,052 | -4,825 | -14,979 |
| Net Income | $-8,663 | $-7,661 | $-3,052 | $-4,825 | $-14,979 |
| EPS Basic Total Ops | -0.41 | -0.36 | -0.07 | -0.29 | -0.89 |
| EPS Basic Continuous Ops | -0.41 | -0.36 | -0.07 | -0.29 | -0.89 |
| EPS Diluted Total Ops | -0.41 | -0.36 | -0.07 | -0.29 | -0.89 |
| EPS Diluted Continuous Ops | -0.41 | -0.36 | -0.07 | -0.29 | -0.89 |
| EBITDA(a) | $-9,079 | $-8,031 | $-3,206 | $-4,647 | $-14,888 |